Daily Journal Staff Writer
WASHINGTON - San Francisco pharmaceutical giant McKesson Corp. agreed to pay more than $190 million to settle federal allegations it defrauded Medicaid by inflating pricing reports for prescription drugs, the U.S. Justice Department announced Thursday.
The department claims McKesson violated the False Claims Act by reporting puffed-up pricing information to South San Francisco-based First DataBank, ...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In